Polycythemia vera disease profile in an African population—experience from a tertiary facility in Ghana

Objectives: The study describes the clinical and laboratory profile of the patients with polycythemia vera at Komfo Anokye Teaching Hospital in Kumasi, Ghana. Methods and design: This was a retrospective hospital-based cohort study conducted from September 2020 to August 2022. Hematology clinic entr...

Full description

Bibliographic Details
Main Authors: Solomon Gyabaah, Eunice Agyemang Ahmed, Adwoa Agyemang Adu-Gyamfi, Frederick Nkrumah Gyabaah, Afia Serwaa Bonsu, Ameyaw Prince Addo, Ohene Kwaku Opare Sem
Format: Article
Language:English
Published: SAGE Publishing 2023-07-01
Series:SAGE Open Medicine
Online Access:https://doi.org/10.1177/20503121231187747
_version_ 1827892426312777728
author Solomon Gyabaah
Eunice Agyemang Ahmed
Adwoa Agyemang Adu-Gyamfi
Frederick Nkrumah Gyabaah
Afia Serwaa Bonsu
Ameyaw Prince Addo
Ohene Kwaku Opare Sem
author_facet Solomon Gyabaah
Eunice Agyemang Ahmed
Adwoa Agyemang Adu-Gyamfi
Frederick Nkrumah Gyabaah
Afia Serwaa Bonsu
Ameyaw Prince Addo
Ohene Kwaku Opare Sem
author_sort Solomon Gyabaah
collection DOAJ
description Objectives: The study describes the clinical and laboratory profile of the patients with polycythemia vera at Komfo Anokye Teaching Hospital in Kumasi, Ghana. Methods and design: This was a retrospective hospital-based cohort study conducted from September 2020 to August 2022. Hematology clinic entry book was used to identify the patient’s unique hospital code. Using these unique codes, retrospective data were collected using an Excel spreadsheet from the Hospital Lightwave health information management system (LHIMS) database. Results: A total of 20 participants were recruited over the period of 2 years. The overall mean age was 51.53 ± 16.39 years. The hematological profile of the male participants revealed a mean hemoglobin of 18.25 ± 1.373 g/dl, mean hematocrit of 52 ± 3.47%, and a mean platelet of 345.5 ± 180.82. Comparatively, the mean hemoglobin, hematocrit, and platelet for the female participants were higher with figures of 19.26 ± 1.43 g/dl, 53 ± 3.61%, and 816 ± 935.32, respectively. Headache, tiredness, numbness, splenomegaly, and abnormal labs were the most common reasons why participants sought medical attention. Majority (60%) of the study participants had Janus Kinase 2 mutation. New-onset hypertension was identified in 45% of the study participants during follow-up. Thromboembolism was seen in 10% of the study population. Conclusion: Polycythemia vera is an uncommon disease in Ghana mostly found in older males above 50 years. It is important to recognize it early to initiate therapy aimed at preventing common complications such as hypertension and thromboembolism. Polycythemia vera should be considered a differential diagnosis for patients with secondary hypertension.
first_indexed 2024-03-12T21:39:37Z
format Article
id doaj.art-92d46950648c4662b36503ff05380a9c
institution Directory Open Access Journal
issn 2050-3121
language English
last_indexed 2024-03-12T21:39:37Z
publishDate 2023-07-01
publisher SAGE Publishing
record_format Article
series SAGE Open Medicine
spelling doaj.art-92d46950648c4662b36503ff05380a9c2023-07-27T05:04:06ZengSAGE PublishingSAGE Open Medicine2050-31212023-07-011110.1177/20503121231187747Polycythemia vera disease profile in an African population—experience from a tertiary facility in GhanaSolomon Gyabaah0Eunice Agyemang Ahmed1Adwoa Agyemang Adu-Gyamfi2Frederick Nkrumah Gyabaah3Afia Serwaa Bonsu4Ameyaw Prince Addo5Ohene Kwaku Opare Sem6Komfo Anokye Teaching Hospital, Kumasi, GhanaKomfo Anokye Teaching Hospital, Kumasi, GhanaKomfo Anokye Teaching Hospital, Kumasi, GhanaTexas Tech University Health Sciences Center El Paso, El Paso, TX, USAKomfo Anokye Teaching Hospital, Kumasi, GhanaBridgeport Hospital/Yale New Haven Health, Bridgeport, CT, USASchool of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, GhanaObjectives: The study describes the clinical and laboratory profile of the patients with polycythemia vera at Komfo Anokye Teaching Hospital in Kumasi, Ghana. Methods and design: This was a retrospective hospital-based cohort study conducted from September 2020 to August 2022. Hematology clinic entry book was used to identify the patient’s unique hospital code. Using these unique codes, retrospective data were collected using an Excel spreadsheet from the Hospital Lightwave health information management system (LHIMS) database. Results: A total of 20 participants were recruited over the period of 2 years. The overall mean age was 51.53 ± 16.39 years. The hematological profile of the male participants revealed a mean hemoglobin of 18.25 ± 1.373 g/dl, mean hematocrit of 52 ± 3.47%, and a mean platelet of 345.5 ± 180.82. Comparatively, the mean hemoglobin, hematocrit, and platelet for the female participants were higher with figures of 19.26 ± 1.43 g/dl, 53 ± 3.61%, and 816 ± 935.32, respectively. Headache, tiredness, numbness, splenomegaly, and abnormal labs were the most common reasons why participants sought medical attention. Majority (60%) of the study participants had Janus Kinase 2 mutation. New-onset hypertension was identified in 45% of the study participants during follow-up. Thromboembolism was seen in 10% of the study population. Conclusion: Polycythemia vera is an uncommon disease in Ghana mostly found in older males above 50 years. It is important to recognize it early to initiate therapy aimed at preventing common complications such as hypertension and thromboembolism. Polycythemia vera should be considered a differential diagnosis for patients with secondary hypertension.https://doi.org/10.1177/20503121231187747
spellingShingle Solomon Gyabaah
Eunice Agyemang Ahmed
Adwoa Agyemang Adu-Gyamfi
Frederick Nkrumah Gyabaah
Afia Serwaa Bonsu
Ameyaw Prince Addo
Ohene Kwaku Opare Sem
Polycythemia vera disease profile in an African population—experience from a tertiary facility in Ghana
SAGE Open Medicine
title Polycythemia vera disease profile in an African population—experience from a tertiary facility in Ghana
title_full Polycythemia vera disease profile in an African population—experience from a tertiary facility in Ghana
title_fullStr Polycythemia vera disease profile in an African population—experience from a tertiary facility in Ghana
title_full_unstemmed Polycythemia vera disease profile in an African population—experience from a tertiary facility in Ghana
title_short Polycythemia vera disease profile in an African population—experience from a tertiary facility in Ghana
title_sort polycythemia vera disease profile in an african population experience from a tertiary facility in ghana
url https://doi.org/10.1177/20503121231187747
work_keys_str_mv AT solomongyabaah polycythemiaveradiseaseprofileinanafricanpopulationexperiencefromatertiaryfacilityinghana
AT euniceagyemangahmed polycythemiaveradiseaseprofileinanafricanpopulationexperiencefromatertiaryfacilityinghana
AT adwoaagyemangadugyamfi polycythemiaveradiseaseprofileinanafricanpopulationexperiencefromatertiaryfacilityinghana
AT fredericknkrumahgyabaah polycythemiaveradiseaseprofileinanafricanpopulationexperiencefromatertiaryfacilityinghana
AT afiaserwaabonsu polycythemiaveradiseaseprofileinanafricanpopulationexperiencefromatertiaryfacilityinghana
AT ameyawprinceaddo polycythemiaveradiseaseprofileinanafricanpopulationexperiencefromatertiaryfacilityinghana
AT ohenekwakuoparesem polycythemiaveradiseaseprofileinanafricanpopulationexperiencefromatertiaryfacilityinghana